Improvement in Health-related Quality of Life with Use of Sebetralstat as On-Demand Treatment for Hereditary Angioedema Attacks: Results From the KONFIDENT-S Study Stratified[...]

Kalvista Pharmaceuticals Inc. published this content on October 21, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 24, 2026 at 16:06 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]